Corrigendum to "Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic" [Vaccine (2024) 26059].
Vaccine
; 42(23): 126128, 2024 Oct 03.
Article
in En
| MEDLINE
| ID: mdl-39019659
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Vaccine
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Países Bajos